Search Results - "Santich, Brian H"

Refine Results
  1. 1
  2. 2
  3. 3

    Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release by Park, Jeong A, Santich, Brian H, Xu, Hong, Lum, Lawrence G, Cheung, Nai-Kong V

    Published in Journal for immunotherapy of cancer (01-05-2021)
    “…BackgroundT cell-based immunotherapies using chimeric antigen receptors (CAR) or bispecific antibodies (BsAb) have produced impressive responses in…”
    Get full text
    Journal Article
  4. 4

    Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma by Long, Alan W, Xu, Hong, Santich, Brian H, Guo, Hongfen, Hoseini, Sayed Shahabuddin, de Stanchina, Elisa, Cheung, Nai-Kong V

    Published in Journal of hematology and oncology (23-04-2024)
    “…EGFR and/or HER2 expression in pancreatic cancers is correlated with poor prognoses. We generated homodimeric (EGFRxEGFR or HER2xHER2) and heterodimeric…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies by Ahmed, Mahiuddin, Lopez-Albaitero, Andres, Pankov, Dmitry, Santich, Brian H, Liu, Hong, Yan, Su, Xiang, Jingyi, Wang, Pei, Hasan, Aisha N, Selvakumar, Annamalai, O'Reilly, Richard J, Liu, Cheng, Cheung, Nai-Kong V

    Published in JCI insight (22-02-2018)
    “…EBV infection is associated with a number of malignancies of clinical unmet need, including Hodgkin lymphoma, nasopharyngeal carcinoma, gastric cancer, and…”
    Get full text
    Journal Article
  8. 8

    Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells by Zompi, Simona, Santich, Brian H, Beatty, P Robert, Harris, Eva

    Published in The Journal of immunology (1950) (01-01-2012)
    “…The four dengue virus (DENV) serotypes cause dengue fever and dengue hemorrhagic fever/dengue shock syndrome. Although severe disease has been associated with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors by Cheng, Ming, Santich, Brian H., Xu, Hong, Ahmed, Mahiuddin, Huse, Morgan, Cheung, Nai-Kong V.

    Published in Oncoimmunology (02-06-2016)
    “…Engineering potent bispecific antibodies from single-chain variable fragments (scFv) remains difficult due to the inherent instability and insufficient binding…”
    Get full text
    Journal Article
  14. 14

    Targeting Intracellular Antigens with pMHC-Binding Antibodies: A Phage Display Approach by Wu, Zhihao, Santich, Brian H, Liu, Hong, Liu, Cheng, Cheung, Nai-Kong V

    “…Antibodies that bind peptide-MHC (pMHC) complex in a manner akin to T-cell receptor (TCR) have not only helped in understanding the mechanism of TCR-pMHC…”
    Get more information
    Journal Article
  15. 15

    Gravesʹ disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4+ T-cell recovery by SHEIKH, Virginia, DERSIMONIAN, Rebecca, MOIR, Susan, SERETI, Irini, RICHTERMAN, Aaron G, PORTER, Brian O, NATARAJAN, Ven, BURBELO, Peter D, RUPERT, Adam, SANTICH, Brian H, KARDAVA, Lela, MICAN, JoAnn M

    Published in AIDS (London) (02-01-2014)
    “…Immune restoration disease (IRD) can develop in HIV-infected patients following antiretroviral therapy (ART) initiation as unmasking or paradoxical worsening…”
    Get full text
    Journal Article
  16. 16

    Generation of TCR-Like Antibodies Using Phage Display by Santich, Brian H, Liu, Hong, Liu, Cheng, Cheung, Nai-Kong V

    “…The adaptive immune response against cancer consists of two arms: the humoral response from B cells, and the cell-mediated response from T cells. The humoral…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20